Azacytidine, Bendamustine, Piamprizumab in Refractory/Relapsed B-cell Non-Hodgkin's Lymphoma

NCT04897477 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Non-hodgkin Lymphoma,B Cell

Interventions

DRUG: Azacytidine, Bendamustine and Piamprizumab

Sponsor

Chinese PLA General Hospital